Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
84.26
+2.62 (+3.21%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
↗
September 17, 2022
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read.
Via
Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
↗
September 15, 2022
Via
Benzinga
FDA Approves Edwards Lifesciences' PASCAL Precision Transcatheter Valve Repair System For Most Frequent Cardiovascular Disorder
↗
September 15, 2022
Via
Benzinga
Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics
↗
August 17, 2022
Agilent managed to stave off challenges due to Covid and exchange rates for a big beat.
Via
Investor's Business Daily
Edwards Lifesciences Whale Trades Spotted
↗
August 05, 2022
Someone with a lot of money to spend has taken a bullish stance on Edwards Lifesciences (NYSE:EW). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook
↗
July 28, 2022
Via
Benzinga
Expert Ratings for Edwards Lifesciences
↗
July 18, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Via
Benzinga
Where Edwards Lifesciences Stands With Analysts
↗
May 17, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Via
Benzinga
Analyzing Edwards Lifesciences's Short Interest
↗
August 03, 2022
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 6.93% since its last report. The company recently reported that it has 6.66 million shares sold short, which is 1...
Via
Benzinga
Here's How Much $100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
↗
July 29, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.8%. Currently, Edwards Lifesciences has a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
↗
July 29, 2022
Via
Benzinga
Roku, Intel And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
July 29, 2022
Via
Benzinga
Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales
↗
April 27, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
July 29, 2022
Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 28, 2022
Gainers
Via
Benzinga
Recap: Edwards Lifesciences Q2 Earnings
↗
July 28, 2022
Edwards Lifesciences (NYSE:EW) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Edwards Lifesciences Wipes Out Regular-Session Gains On 2022 Guidance Cut
↗
July 28, 2022
Edwards Lifesciences now expects sales to grow just 10% on an underlying basis. Exchange rates and hospital staffing are challenging growth.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
↗
July 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
↗
July 18, 2022
Edwards Lifesciences's (NYSE:EW) short percent of float has fallen 64.56% since its last report. The company recently reported that it has 6.21 million shares sold short, which is...
Via
Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
↗
July 13, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 17.08% on an annualized basis producing an average annual return of 23.24%. Currently, Edwards Lifesciences has a...
Via
Benzinga
Analyzing Edwards Lifesciences's Short Interest
↗
June 30, 2022
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 166.36% since its last report. The company recently reported that it has 5.87 million shares sold short, which is...
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $600 Today
↗
June 28, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 7.85% on an annualized basis producing an average annual return of 18.65%. Currently, Edwards Lifesciences has a...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
June 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More
↗
June 22, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy.
Via
Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
↗
June 14, 2022
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 6.33% since its last report. The company recently reported that it has 5.15 million shares sold short, which is 0...
Via
Benzinga
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
↗
June 13, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 16.51% on an annualized basis producing an average annual return of 22.72%. Currently, Edwards Lifesciences has a...
Via
Benzinga
7 Growth Stocks That Analysts Love Right Now
↗
May 17, 2022
These growth stocks are receiving buy ratings and significantly higher price targets from analysts, making them ideal names to consider.
Via
InvestorPlace
Why Jim Cramer Prefers These 2 Semiconductor Stocks
↗
May 03, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc. (NASDAQ: SOFI) has been getting destroyed.
Via
Benzinga
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
↗
April 29, 2022
The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings.
Via
Investor's Business Daily
If You Invested $100 In Edwards Lifesciences 20 Years Ago, Here's How Much You Would Have Today
↗
April 27, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 14.71% on an annualized basis producing an average annual return of 21.87%. Currently, Edwards Lifesciences has a...
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.